SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-18-007347
Filing Date
2018-04-20
Accepted
2018-04-20 16:48:34
Documents
8
Period of Report
2018-06-14

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A dffn20180420_pre14a.htm PRE 14A 600524
2 notice4.jpg GRAPHIC 59376
3 notice3.jpg GRAPHIC 68667
4 notice2.jpg GRAPHIC 143068
5 notice1.jpg GRAPHIC 126058
6 proxy2.jpg GRAPHIC 104426
7 proxy1.jpg GRAPHIC 237603
8 dffn20180420_pre14aimg001.jpg GRAPHIC 10370
  Complete submission text file 0001437749-18-007347.txt   1634528
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37942 | Film No.: 18767280
SIC: 2834 Pharmaceutical Preparations